{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T05:08:22Z","timestamp":1734239302062,"version":"3.30.2"},"reference-count":225,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1097\/01.crd.0000053459.09918.92","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T10:46:15Z","timestamp":1068547575000},"page":"122-146","source":"Crossref","is-referenced-by-count":0,"title":["Drug Therapy of Neurovascular Disease"],"prefix":"10.1097","volume":"11","author":[{"given":"JESSE","family":"WEINBERGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM H.","family":"FRISHMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAWN","family":"TERASHITA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/01.STR.6.3.245","article-title":"Regional cerebral blood flow estimated by 133Xenon inhalation","volume":"6","author":"Obrist","year":"1975","journal-title":"Stroke"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"444S","DOI":"10.1378\/chest.108.4_Supplement.444S","article-title":"Antithrombotic therapy for cerebrovascular disorders: an update","volume":"106","author":"Sherman","year":"1995","journal-title":"Chest"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.STR.19.9.1083","article-title":"The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke","volume":"19","author":"Bogousslavsky","year":"1988","journal-title":"Stroke"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1212\/WNL.20.1.82","article-title":"Nature of occlusions of the middle cerebral artery","volume":"20","author":"Lhermitte","year":"1970","journal-title":"Neurology"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0002-9343(97)89525-3","article-title":"Cardioembolic stroke","volume":"100","author":"Brickner","year":"1996","journal-title":"Am J Med"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM198108063050601","article-title":"Incidence of left-ventricular thrombosis after acute transmural myocardial infarction: serial evaluation by 2 dimensional echocardiography","volume":"305","author":"Asinger","year":"1981","journal-title":"N Engl J Med"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1212\/WNL.15.8.774","article-title":"Lacunes: small, deep cerebral infarcts","volume":"15","author":"Fisher","year":"1965","journal-title":"Neurology"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1001\/jama.283.16.2122","article-title":"Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis","volume":"283","author":"Silvestrini","year":"2000","journal-title":"JAMA"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/WNL.36.3.373","article-title":"Unilateral watershed cerebral infarcts","volume":"36","author":"Bogousslavsky","year":"1986","journal-title":"Neurology"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-4886(66)90062-8","article-title":"Effects of ischemia and other procedures on the brain and retina of the gerbil (Meriones unguiculatus)","volume":"16","author":"Levine","year":"1966","journal-title":"Exp Neurol"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJM199109193251207","article-title":"Transient monocular blindness caused by vasospasm","volume":"325","author":"Burger","year":"1991","journal-title":"N Engl J Med"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1001\/archneur.1987.00520200070022","article-title":"Migraine-related strokes","volume":"44","author":"Broderick","year":"1987","journal-title":"Arch Neurol"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.410140602","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: an update","volume":"14","author":"Heros","year":"1983","journal-title":"Ann Neurol"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurological manifestations of systemic lupus erythematosus","volume":"47","author":"Johnson","year":"1968","journal-title":"Medicine"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/WNL.43.10.2069","article-title":"Anticardiolipin antibodies are an independent risk factor for first ischemic stroke","volume":"43","year":"1993","journal-title":"Neurology"},{"key":"R17-4-20210203","first-page":"1445","article-title":"Acquired deficiencies of protein S","volume":"81","author":"D\u2019Angelo","year":"1998","journal-title":"J Clin Invest"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V63.1.162.162","article-title":"Effect of transfusion therapy on arteriographic abnormalities and on the recurrence of stroke in sickle cell disease","volume":"63","author":"Russell","year":"1984","journal-title":"Blood"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/path.1700930202","article-title":"The occurrence and significance of intracerebral micro-aneurysms","volume":"93","author":"Cote","year":"1967","journal-title":"J Path Bact"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.STR.18.2.311","article-title":"Cerebral amyloid angiopathy: a critical review","volume":"18","author":"Vinters","year":"1987","journal-title":"Stroke"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1161\/01.STR.20.8.1117","article-title":"Hemorrhagic transformation of cardioembolic stroke","volume":"20","author":"Hart","year":"1989","journal-title":"Stroke"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00005792-197807000-00004","article-title":"Neurologic complications of bacterial endocarditis","volume":"57","author":"Pruitt","year":"1978","journal-title":"Medicine"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archneur.1968.00470340044003","article-title":"Thrombotic thrombocytopenic purpura: the initial neurologic manifestations","volume":"18","author":"Silverstein","year":"1968","journal-title":"Arch Neurol"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.CIR.103.1.163","article-title":"Primary prevention if ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association","volume":"103","author":"Goldstein","year":"2001","journal-title":"Circulation"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/01.STR.7.4.327","article-title":"Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham Study","volume":"7","author":"Kannel","year":"1976","journal-title":"Stroke"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2165\/00003495-199958040-00006","article-title":"Antihypertensive therapy in the prevention of stroke: what, when and for whom?","volume":"58","author":"Fotherby","year":"1999","journal-title":"Drugs"},{"key":"R28-4-20210203","first-page":"1142","article-title":"Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressures averaging 90 through 114 mmHg","volume":"213","year":"1970","journal-title":"JAMA"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.1974.03230420021019","article-title":"Effect of antihypertensive treatment on stroke recurrence","volume":"229","year":"1974","journal-title":"JAMA"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","year":"1991","journal-title":"JAMA"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-126-10-199705150-00002","article-title":"Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men: a meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators","volume":"126","author":"Gueyffier","year":"1997","journal-title":"Ann Intern Med"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.161.1.37","article-title":"Antihypertensive drug therapies and the risk of ischemic stroke","volume":"161","author":"Klungel","year":"2001","journal-title":"Arch Intern Med"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.1997.00440420033005","article-title":"The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.STR.31.2.420","article-title":"Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients","volume":"31","author":"Klungel","year":"2000","journal-title":"Stroke"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.284.4.465","article-title":"Effect of treating isolated systolic hyper-tension on the risk of developing various types and subtypes of stroke. The Systolic Hypertension in the Elderly Program (SHEP)","volume":"284","author":"Perry","year":"2000","journal-title":"JAMA"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10641969909060982","article-title":"Treatment of isolated systolic hypertension in the elderly: Systolic Hypertension in Europe (Syst-Eur) Trial Investigators","volume":"21","author":"Fagard","year":"1999","journal-title":"Clin Exp Hypertens"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.HYP.34.6.1181","article-title":"J-shaped relation between blood pressure and stroke in treated hypertensives","volume":"34","author":"Voko","year":"1999","journal-title":"Hypertension"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1161\/01.STR.28.9.1702","article-title":"Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden","volume":"28","author":"Kristensen","year":"1997","journal-title":"Stroke"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJM200012213432501","article-title":"Phenylpropanolamine and the risk of hemorrhagic stroke","volume":"343","author":"Kernan","year":"2000","journal-title":"N Engl J Med"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJM200012213432510","article-title":"The FDA, regulation, and the risk of stroke. (Editorial)","volume":"343","author":"Fleming","year":"2000","journal-title":"N Engl J Med"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham Study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"R43-4-20210203","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJM199004053221406","article-title":"Diabetic retinopathy: a synthesis of perspectives","volume":"322","author":"Merimee","year":"1990","journal-title":"N Engl J Med"},{"key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archneur.1990.00530110028011","article-title":"The influence of hyperglycemia and diabetes mellitus on immediate and 3 month morbidity and mortality after acute stroke","volume":"47","author":"Woo","year":"1990","journal-title":"Arch Neurol"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"R46-4-20210203","first-page":"145","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","year":"1999","journal-title":"N Engl J Med"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","article-title":"Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"R48-4-20210203","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High-density lipoprotein as a protective factor against coronary heart disease: the Framingham Study","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"R49-4-20210203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R50-4-20210203","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0735-1097(98)00202-2","article-title":"Effect of pravastatin on cardiovascular events in women after myocardial infarction: the Cholesterol and Recurrent Events (CARE) trial","volume":"32","author":"Lewis","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R51-4-20210203","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","article-title":"Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study","volume":"99","author":"Plehn","year":"1999","journal-title":"Circulation"},{"key":"R52-4-20210203","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"R53-4-20210203","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.1997.03550040069040","article-title":"Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials","volume":"278","author":"Herbert","year":"1997","journal-title":"JAMA"},{"key":"R54-4-20210203","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.28.5.946","article-title":"Stroke, statins, and cholesterol: a meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors","volume":"28","author":"Blauw","year":"1997","journal-title":"Stroke"},{"key":"R55-4-20210203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-128-2-199801150-00002","article-title":"Effect of HMG-CoA reductase inhibitors on stroke: a meta-analysis of randomized, controlled trials","volume":"128","author":"Bucher","year":"1998","journal-title":"Ann Intern Med"},{"key":"R56-4-20210203","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archinte.1997.00440330039004","article-title":"Reductase inhibitor monotherapy and stroke prevention","volume":"157","author":"Crouse","year":"1997","journal-title":"Arch Intern Med"},{"key":"R57-4-20210203","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1525-1497.1999.02109.x","article-title":"Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke","volume":"14","author":"Warshafsky","year":"1999","journal-title":"J Gen Intern Med"},{"key":"R58-4-20210203","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"key":"R59-4-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM200008033430502","article-title":"Pravastatin therapy and the risk of stroke","volume":"343","author":"White","year":"2000","journal-title":"N Engl J Med"},{"key":"R60-4-20210203","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/jama.281.12.1112","article-title":"Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association","volume":"281","author":"Gorelick","year":"1999","journal-title":"JAMA"},{"key":"R61-4-20210203","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.282.13.1233","article-title":"Fruit and vegetable intake in relation to risk of ischemic stroke","volume":"282","author":"Joshipura","year":"1999","journal-title":"JAMA"},{"key":"R62-4-20210203","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/ajcn\/72.2.476","article-title":"Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women","volume":"72","author":"Yochum","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"R63-4-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF00210955","article-title":"Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study","volume":"71","author":"Gey","year":"1993","journal-title":"Clin Invest"},{"key":"R64-4-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.ATV.20.1.230","article-title":"Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers","volume":"20","author":"Leppala","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R65-4-20210203","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-130-12-199906150-00003","article-title":"Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States","volume":"130","author":"Ascherio","year":"1999","journal-title":"Ann Intern Med"},{"key":"R66-4-20210203","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N Engl J Med"},{"key":"R67-4-20210203","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(95)92836-7","article-title":"Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"R68-4-20210203","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial (MRFIT)","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"R69-4-20210203","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.STR.20.11.1460","article-title":"Serum cholesterol and hemorrhagic stroke in the Honolulu heart program","volume":"20","author":"Yano","year":"1989","journal-title":"Stroke"},{"key":"R70-4-20210203","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/01.STR.24.7.954","article-title":"Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study","volume":"24","author":"Konishi","year":"1993","journal-title":"Stroke"},{"key":"R71-4-20210203","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0889-8529(05)70249-8","article-title":"The effects of hormone replacement therapy on coronary heart disease","volume":"26","author":"Sotelo","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R72-4-20210203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R73-4-20210203","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1172\/JCI108132","article-title":"The mechanism of the effect of aspirin on human platelet, I: acetylation of a particular fraction protein","volume":"56","author":"Roth","year":"1975","journal-title":"J Clin Invest"},{"key":"R74-4-20210203","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM197807132990201","article-title":"A randomized trial of aspirin and sulfinpyrazone in threatened stroke","volume":"299","year":"1978","journal-title":"N Engl J Med"},{"key":"R75-4-20210203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.STR.20.1.34","article-title":"Sex difference in antithrombotic effects of aspirin","volume":"20","author":"Spranger","year":"1989","journal-title":"Stroke"},{"key":"R76-4-20210203","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom Transient Ischemic Attack (UK-TIA) aspirin trial: final results","volume":"54","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R77-4-20210203","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"R78-4-20210203","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0140-6736(91)92233-R","article-title":"Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"R79-4-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R80-4-20210203","first-page":"1","article-title":"The effect of antiplatelet agents on survival free of new stroke: a meta-analysis","volume":"8","author":"Jonas","year":"1998","journal-title":"Stroke Clin Updates"},{"key":"R81-4-20210203","doi-asserted-by":"crossref","first-page":"683S","DOI":"10.1378\/chest.114.5_Supplement.683S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"114","author":"Albers","year":"1998","journal-title":"Chest"},{"key":"R83-4-20210203","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.STR.23.10.1395","article-title":"Low-dose aspirin and stroke: \u201cIt ain\u2019t necessarily so.\u201d","volume":"23","author":"Dyken","year":"1992","journal-title":"Stroke"},{"key":"R84-4-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"R85-4-20210203","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/01.STR.29.2.554","article-title":"Guidelines for carotid endarterectomy: a statement for health-care professionals from a Special Writing Group of the Stroke Council, American Heart Association","volume":"29","author":"Biller","year":"1998","journal-title":"Stroke"},{"key":"R86-4-20210203","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"R87-4-20210203","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(97)11475-1","article-title":"Thrombosis prevention trial: randomized trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"R88-4-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"R89-4-20210203","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","article-title":"A randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R90-4-20210203","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","article-title":"A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R91-4-20210203","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/01.STR.31.6.1240","article-title":"Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial","volume":"31","author":"Chen","year":"2000","journal-title":"Stroke"},{"key":"R92-4-20210203","first-page":"64","article-title":"Pharmacological evaluation of ticlopidine, a novel inhibitor of platelet function","volume":"38","author":"Johnson","year":"1977","journal-title":"Thromb Haemost"},{"key":"R93-4-20210203","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"N Engl J Med"},{"key":"R94-4-20210203","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1212\/WNL.42.1.111","article-title":"Prevention of stroke with ticlopidine: who benefits most?","volume":"42","author":"Grotta","year":"1992","journal-title":"Neurology"},{"key":"R95-4-20210203","first-page":"33","article-title":"A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study","volume":"12","author":"Bergamasco","year":"1997","journal-title":"Funct Neurol"},{"key":"R96-4-20210203","first-page":"1215","article-title":"The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke","volume":"1","author":"Blakely","year":"1989","journal-title":"Lancet"},{"key":"R97-4-20210203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-128-7-199804010-00004","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine: a review of 60 cases","volume":"128","author":"Bennett","year":"1998","journal-title":"Ann Intern Med"},{"key":"R98-4-20210203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00003495-199754050-00006","article-title":"Clopidogrel","volume":"54","author":"Coukell","year":"1997","journal-title":"Drugs"},{"key":"R99-4-20210203","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R100-4-20210203","doi-asserted-by":"crossref","first-page":"300s","DOI":"10.1378\/chest.119.1_suppl.300S","article-title":"Antithrombotic and thrombolytic therapy for ischemic stroke","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"R101-4-20210203","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJM200006153422402","article-title":"Thrombotic thrombocytopenic purpura associated with clopidogrel","volume":"342","author":"Bennett","year":"2000","journal-title":"N Engl J Med"},{"key":"R102-4-20210203","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","article-title":"Dipyridamole","volume":"316","author":"Fitzgerald","year":"1987","journal-title":"N Engl J Med"},{"key":"R103-4-20210203","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/0002-9149(83)90673-2","article-title":"Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole","volume":"51","author":"Cheseboro","year":"1983","journal-title":"Am J Cardiol"},{"key":"R104-4-20210203","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.1.5644.614","article-title":"Controlled trial of dipyridamole in cerebral vascular disease","volume":"1","author":"Acheson","year":"1969","journal-title":"BMJ"},{"key":"R105-4-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"R106-4-20210203","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archinte.160.11.1579","article-title":"Update on antiplatelet therapy for stroke prevention","volume":"160","author":"Sacco","year":"2000","journal-title":"Arch Intern Med"},{"key":"R107-4-20210203","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.51.3_Suppl_3.S15","article-title":"Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results","volume":"51","author":"Tijssen","year":"1998","journal-title":"Neurology"},{"key":"R108-4-20210203","doi-asserted-by":"crossref","first-page":"47C","DOI":"10.1016\/S0002-9149(00)00878-X","article-title":"Potential role of abciximab in ischemic cerebrovascular disease","volume":"85","author":"Winkley","year":"2000","journal-title":"Am J Cardiol"},{"key":"R109-4-20210203","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/bmj.1.5392.1209","article-title":"Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease","volume":"1","author":"Szekely","year":"1964","journal-title":"BMJ"},{"key":"R110-4-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","article-title":"Predictors of thromboembolism in atrial fibrillation, I: clinical features of patients at risk","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"key":"R111-4-20210203","first-page":"587","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R112-4-20210203","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archinte.158.14.1513","article-title":"Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study","volume":"158","author":"Gullov","year":"1998","journal-title":"Arch Intern Med"},{"key":"R113-4-20210203","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"R114-4-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"R115-4-20210203","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1001\/jama.281.19.1830","article-title":"Preventing stroke in patients with atrial fibrillation","volume":"281","author":"Ezekowitz","year":"1999","journal-title":"JAMA"},{"key":"R116-4-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199007193230302","article-title":"The effect of warfarin on mortality and reinfarction after myocardial infarction","volume":"323","author":"Smith","year":"1990","journal-title":"N Engl J Med"},{"key":"R117-4-20210203","first-page":"499","article-title":"Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R118-4-20210203","doi-asserted-by":"crossref","first-page":"228s","DOI":"10.1378\/chest.119.1_suppl.228S","article-title":"Antithrombotic agents in coronary artery disease","volume":"119","author":"Cairns","year":"2001","journal-title":"Chest"},{"key":"R119-4-20210203","doi-asserted-by":"crossref","first-page":"194s","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"R120-4-20210203","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/WNL.45.8.1488","article-title":"The warfarin-aspirin symptomatic intracranial disease study","volume":"45","author":"Chimowitz","year":"1988","journal-title":"Neurology"},{"key":"R121-4-20210203","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0735-1097(99)00003-0","article-title":"Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants","volume":"33","author":"Ferrari","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R122-4-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9343(98)00414-8","article-title":"Diagnosis and treatment of ischemic stroke","volume":"106","author":"Alberts","year":"1999","journal-title":"Am J Med"},{"key":"R123-4-20210203","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.57.12.1685","article-title":"The insula and cerebrogenic sudden death","volume":"57","author":"Cheung","year":"2000","journal-title":"Arch Neurol"},{"key":"R124-4-20210203","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/jama.1981.03320190035023","article-title":"Blood pressure after stroke","volume":"246","author":"Wallace","year":"1981","journal-title":"JAMA"},{"key":"R125-4-20210203","first-page":"309","article-title":"Stroke management in the diabetic patient: diagnosis, treatment, and prevention","volume":"14","author":"Bell","year":"1999","journal-title":"J Crit Illness"},{"key":"R126-4-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.STR.31.3.601","article-title":"A randomized, double-blind, placebo-controlled, dose escalation study","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"R127-4-20210203","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/WNL.8.5.311","article-title":"The use of anticoagulants in cerebral thrombosis","volume":"8","author":"Fisher","year":"1958","journal-title":"Neurology"},{"key":"R128-4-20210203","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archneur.1995.00540310040014","article-title":"Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis and prognosis","volume":"52","author":"Toni","year":"1995","journal-title":"Arch Neurol"},{"key":"R129-4-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.STR.19.1.10","article-title":"Failure of heparin to prevent progression in progressing ischemic stroke","volume":"19","author":"Haley","year":"1988","journal-title":"Stroke"},{"key":"R130-4-20210203","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"key":"R131-4-20210203","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-105-6-825","article-title":"Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial","volume":"105","author":"Duke","year":"1986","journal-title":"Ann Intern Med"},{"key":"R132-4-20210203","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial","volume":"279","year":"1998","journal-title":"JAMA"},{"key":"R133-4-20210203","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM199512143332402","article-title":"Low molecular weight heparin for the treatment of acute ischemic stroke","volume":"333","author":"Kay","year":"1995","journal-title":"N Engl J Med"},{"key":"R134-4-20210203","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(01)05837-8","article-title":"Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial","volume":"358","author":"Bath","year":"2001","journal-title":"Lancet"},{"key":"R135-4-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.STR.20.3.317","article-title":"Hypervolemic hemodilution treatment of acute stroke: results of a randomized multicenter trial using pentastarch","volume":"20","year":"1989","journal-title":"Stroke"},{"key":"R136-4-20210203","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.STR.29.4.743","article-title":"Hypervolemic hemodilution in acute ischemic stroke: the Multicenter Austrian Hemodilution Stroke Trial (MAHST)","volume":"29","author":"Aichner","year":"1998","journal-title":"Stroke"},{"key":"R137-4-20210203","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.STR.29.9.1888","article-title":"Early hemicraniectomy in patients with complete middle cerebral artery infarction","volume":"29","author":"Schwab","year":"1998","journal-title":"Stroke"},{"key":"R138-4-20210203","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0033-0620(99)70001-0","article-title":"Thrombolysis for acute stroke","volume":"42","author":"Lyden","year":"1999","journal-title":"Prog Cardiovasc Dis"},{"key":"R139-4-20210203","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0140-6736(95)92049-8","article-title":"Italy (MAST-I) Group: Randomized controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"R140-4-20210203","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM199607183350301","article-title":"Thrombolytic therapy with streptokinase in acute ischemic stroke","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"R141-4-20210203","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.1996.03540120039031","article-title":"Streptokinase for acute ischemic stroke with relationship to time of administration","volume":"276","author":"Donnan","year":"1996","journal-title":"JAMA"},{"key":"R142-4-20210203","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.CIR.94.5.1167","article-title":"Guidelines for thrombolytic therapy for acute stroke: a supplement to guidelines for the management of patients with acute ischemic stroke","volume":"94","author":"Adams","year":"1996","journal-title":"Circulation"},{"key":"R143-4-20210203","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"R144-4-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/01.STR.29.1.18","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice","volume":"29","author":"Chiu","year":"1998","journal-title":"Stroke"},{"key":"R145-4-20210203","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"N Engl J Med"},{"key":"R146-4-20210203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"R147-4-20210203","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"R148-4-20210203","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.282.21.2019","article-title":"Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset","volume":"282","author":"Clark","year":"1999","journal-title":"JAMA"},{"key":"R149-4-20210203","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.55.11.1649","article-title":"Early stroke treatment associated with better outcome. The NINDS rt-PA Stroke Study","volume":"55","author":"Marler","year":"2000","journal-title":"Neurology"},{"key":"R150-4-20210203","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1001\/jama.283.23.3102","article-title":"Recommendations for the establishment of primary stroke centers","volume":"283","author":"Alberts","year":"2000","journal-title":"JAMA"},{"key":"R151-4-20210203","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.STR.31.2.370","article-title":"Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA Stroke Survey experience","volume":"31","author":"Tanne","year":"2000","journal-title":"Stroke"},{"key":"R152-4-20210203","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/jama.283.9.1145","article-title":"Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) Study","volume":"283","author":"Albers","year":"2000","journal-title":"JAMA"},{"key":"R153-4-20210203","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.283.9.1151","article-title":"Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience","volume":"283","author":"Katzan","year":"2000","journal-title":"JAMA"},{"key":"R154-4-20210203","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2165\/00003495-200161100-00007","article-title":"Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics","volume":"61","author":"Tanne","year":"2001","journal-title":"Drugs"},{"key":"R155-4-20210203","first-page":"753","article-title":"Local intraarterial fibrinolysis in the carotid territory","volume":"10","author":"Theron","year":"1989","journal-title":"Am J Neuroradiol"},{"key":"R156-4-20210203","first-page":"401","article-title":"Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease","volume":"4","author":"Zeumer","year":"1983","journal-title":"Am J Neuroradiol"},{"key":"R157-4-20210203","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.282.21.2003","article-title":"Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial","volume":"282","author":"Furlan","year":"1999","journal-title":"JAMA"},{"key":"R158-4-20210203","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1001\/jama.283.18.2395","article-title":"Intravenous ancrod for treatment of acute ischemic stroke: the STAT Study: a randomized controlled trial","volume":"283","author":"Sherman","year":"2000","journal-title":"JAMA"},{"key":"R159-4-20210203","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/WNL.32.3.283","article-title":"Recurrent embolic cerebral infarction and anticoagulation","volume":"32","author":"Koller","year":"1982","journal-title":"Neurology"},{"key":"R160-4-20210203","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1161\/01.STR.14.5.668","article-title":"Immediate anticoagulation of embolic stroke: a randomized trial","volume":"14","year":"1983","journal-title":"Stroke"},{"key":"R161-4-20210203","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.STR.15.5.779","article-title":"Immediate anticoagulation of embolic stroke: brain hemorrhage and management options","volume":"15","year":"1984","journal-title":"Stroke"},{"key":"R162-4-20210203","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1212\/WNL.43.7.1298","article-title":"Safety of anticoagulation after hemorrhagic infarction","volume":"43","author":"Pessin","year":"1993","journal-title":"Neurology"},{"key":"R163-4-20210203","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/01.STR.31.11.2563","article-title":"Safety and cost of low-molecular-weight heparin as bridging anticoagulant therapy in subacute cerebral ischemia","volume":"31","author":"Kalafut","year":"2000","journal-title":"Stroke"},{"key":"R164-4-20210203","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/01.STR.8.6.684","article-title":"Diaschisis with cerebral infarction","volume":"8","author":"Slater","year":"1977","journal-title":"Stroke"},{"key":"R165-4-20210203","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1056\/NEJM197510022931407","article-title":"Brain edema","volume":"293","author":"Fishman","year":"1975","journal-title":"N Engl J Med"},{"key":"R166-4-20210203","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bmj.2.6143.994","article-title":"Dexamethasone in acute stroke","volume":"2","author":"Mulley","year":"1978","journal-title":"BMJ"},{"key":"R167-4-20210203","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/archneur.1990.00530050092017","article-title":"Seizures following carotid endarterectomy","volume":"47","author":"Kieburtz","year":"1990","journal-title":"Arch Neurol"},{"key":"R168-4-20210203","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.STR.6.4.353","article-title":"Therapy against brain swelling in stroke patients","volume":"6","author":"Candelise","year":"1975","journal-title":"Stroke"},{"key":"R169-4-20210203","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(72)92775-4","article-title":"Double-blind evaluation of glycerol therapy in acute cerebral infarction","volume":"2","author":"Mathew","year":"1972","journal-title":"Lancet"},{"key":"R170-4-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archneur.1990.00530020053014","article-title":"Epileptic seizures in acute stroke","volume":"47","author":"Kilpatrick","year":"1990","journal-title":"Arch Neurol"},{"key":"R171-4-20210203","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199011223232107","article-title":"The evaluation and treatment of seizures","volume":"323","author":"Scheuer","year":"1990","journal-title":"N Engl J Med"},{"key":"R172-4-20210203","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1532-5415.1998.tb06015.x","article-title":"Vascular dementia: a contemporary review of epidemiology, diagnosis, prevention, and treatment","volume":"46","author":"Nyenhuis","year":"1998","journal-title":"J Am Geriatr Soc"},{"key":"R173-4-20210203","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.1986.03380160061021","article-title":"Improved cognition after control of risk factors for multi-infarct dementia","volume":"256","author":"Meyer","year":"1986","journal-title":"JAMA"},{"key":"R174-4-20210203","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1989.tb05688.x","article-title":"Randomized clinical trial of daily aspirin therapy in multi-infarct dementia","volume":"37","author":"Meyer","year":"1989","journal-title":"J Am Geriatr Soc"},{"key":"R175-4-20210203","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000117279","article-title":"European Pentoxifylline Multi-Infarct Dementia Study","volume":"36","year":"1996","journal-title":"Eur Neurol"},{"key":"R176-4-20210203","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000106650","article-title":"A 12 month, randomized, placebo-controlled trial of propentoxifylline (HWA 285) in patients with dementia according to DSM III-R","volume":"8","author":"Marcusson","year":"1997","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R177-4-20210203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00002826-199619060-00003","article-title":"A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis","volume":"19","author":"Pantoni","year":"1996","journal-title":"Clin Neuropharmacol"},{"key":"R178-4-20210203","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease: a randomised trial","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"Lancet"},{"key":"R179-4-20210203","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(02)08283-1","article-title":"Galantamine for vascular dementia: some answers, some questions","volume":"359","author":"Schneider","year":"2002","journal-title":"Lancet"},{"key":"R180-4-20210203","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ana.410240216","article-title":"A crossover trial of bromocriptine in the treatment of vascular dementia","volume":"24","author":"Nadeau","year":"1988","journal-title":"Ann Neurol"},{"key":"R181-4-20210203","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1523\/JNEUROSCI.04-07-01884.1984","article-title":"Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death","volume":"4","author":"Rothman","year":"1984","journal-title":"J Neurosci"},{"key":"R182-4-20210203","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM199911113412011","article-title":"Reducing calcium overload in the ischemic brain","volume":"341","author":"Zipfel","year":"1999","journal-title":"N Engl J Med"},{"key":"R183-4-20210203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.STR.26.3.503","article-title":"Clinical experience with excitatory amino acid antagonist drugs","volume":"26","author":"Muir","year":"1995","journal-title":"Stroke"},{"key":"R184-4-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.STR.31.2.347","article-title":"Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist","volume":"31","author":"Davis","year":"2000","journal-title":"Stroke"},{"key":"R185-4-20210203","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(00)02326-6","article-title":"Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial","volume":"355","author":"Lees","year":"2000","journal-title":"Lancet"},{"key":"R186-4-20210203","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1001\/jama.285.13.1719","article-title":"Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial","volume":"285","author":"Sacco","year":"2001","journal-title":"JAMA"},{"key":"R187-4-20210203","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.STR.31.2.358","article-title":"Phase II studies of the glycine antagonist GV150526 in acute stroke: the North American experience","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"R188-4-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3171\/jns.1992.77.2.0169","article-title":"Pathophysiology and treatment of focal cerebral ischemia, part I: pathophysiology","volume":"77","author":"Siesjo","year":"1992","journal-title":"J Neurosurg"},{"key":"R189-4-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3171\/jns.1992.77.3.0337","article-title":"Pathophysiology and treatment of focal cerebral ischemia, part II: mechanisms of damage and treatment","volume":"77","author":"Siesjo","year":"1992","journal-title":"J Neurosurg"},{"key":"R190-4-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.STR.9.5.445","article-title":"Free radicals in cerebral ischemia","volume":"9","author":"Flamm","year":"1978","journal-title":"Stroke"},{"key":"R191-4-20210203","first-page":"4l8","article-title":"Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS)","volume":"25","year":"1994","journal-title":"Stroke"},{"key":"R192-4-20210203","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.STR.27.1.76","article-title":"Lubeluzole in acute ischemic stroke: a double-blind placebo controlled phase II trial","volume":"27","author":"Diener","year":"1996","journal-title":"Stroke"},{"key":"R193-4-20210203","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1161\/01.STR.31.11.2543","article-title":"Lubeluzole in acute ischemic stroke treatment: a double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo","volume":"31","author":"Diener","year":"2000","journal-title":"Stroke"},{"key":"R194-4-20210203","first-page":"287","article-title":"The Clomethiazole Acute Stroke Study (CLASS): efficacy results in a subgroup of 545 patients with total anterior circulation syndrome. (Abstract)","volume":"29","author":"Wahlgren","year":"1988","journal-title":"Stroke"},{"key":"R195-4-20210203","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.STR.28.12.2347","article-title":"Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group","volume":"28","author":"De-Deyn","year":"1997","journal-title":"Stroke"},{"key":"R196-4-20210203","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.49.3.671","article-title":"A randomized dose-response trial of citicoline in acute ischemic stroke","volume":"49","author":"Clark","year":"1997","journal-title":"Neurology"},{"key":"R197-4-20210203","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.272.5262.664","article-title":"Finding new drugs to treat stroke","volume":"272","author":"Barinaga","year":"1996","journal-title":"Science"},{"key":"R198-4-20210203","first-page":"A270","article-title":"The Enlimomab Acute Stroke trial final results. (Abstract)","volume":"48","year":"1997","journal-title":"Neurology"},{"key":"R199-4-20210203","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/01.STR.31.6.1234","article-title":"Cervene (nalmefene) in acute ischemic stroke: final results of a phase III efficacy study","volume":"31","author":"Clark","year":"2000","journal-title":"Stroke"},{"key":"R200-4-20210203","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","article-title":"Transplantation of cultured human neuronal cells for patients with stroke","volume":"55","author":"Kondziolka","year":"2000","journal-title":"Neurology"},{"key":"R201-4-20210203","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0733-8619(18)30319-0","article-title":"The concept of migraine as a state of central neuronal hyperexcitability","volume":"8","author":"Welch","year":"1990","journal-title":"Neurol Clin"},{"key":"R202-4-20210203","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ana.410160202","article-title":"The neurobiology of vascular head pain","volume":"16","author":"Moskowitz","year":"1984","journal-title":"Ann Neurol"},{"key":"R203-4-20210203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann Neurol"},{"key":"R204-4-20210203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.410130609","article-title":"Changes in regional cerebral blood flow during the course of classic migraine attacks","volume":"13","author":"Lauritzen","year":"1983","journal-title":"Ann Neurol"},{"key":"R205-4-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archneur.1988.00520250069023","article-title":"Migrainous stroke","volume":"45","author":"Rothrock","year":"1988","journal-title":"Arch Neurol"},{"key":"R206-4-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM199108013250504","article-title":"Treatment of migraine attacks with sumatriptan","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"R207-4-20210203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199855060-00020","article-title":"Sumatriptan: an updated review of its use in migraine","volume":"55","author":"Perry","year":"1998","journal-title":"Drugs"},{"key":"R208-4-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1526-4610.2000.00091.x","article-title":"Cardiac risk factors and the use of triptans: a survey study","volume":"40","author":"Young","year":"2000","journal-title":"Headache"},{"key":"R209-4-20210203","first-page":"S13","article-title":"Migraine: a pharmacologic review with newer options and delivery modalities","volume":"44","author":"Baumel","year":"1994","journal-title":"Neurology"},{"key":"R210-4-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1963.03700150079013","article-title":"Appraisal of methysergide in the treatment of vascular headaches of the migraine type","volume":"184","author":"Friedman","year":"1963","journal-title":"JAMA"},{"key":"R211-4-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJM196602172740701","article-title":"Fibrotic disorders associated with methysergide therapy for headache","volume":"274","author":"Graham","year":"1966","journal-title":"N Engl J Med"},{"key":"R212-4-20210203","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007611-199807000-00002","article-title":"Cluster headache: Horton\u2019s cephalalgia revisited","volume":"91","author":"Mendizabal","year":"1998","journal-title":"South Med J"},{"key":"R213-4-20210203","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198705143162001","article-title":"Effects of dexamethasone in primary supratentorial intracerebral hemorrhage","volume":"316","author":"Poungvarin","year":"1987","journal-title":"N Engl J Med"},{"key":"R214-4-20210203","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.STR.28.11.2126","article-title":"Surgery for primary intracerebral hemorrhage: is it safe and effective?","volume":"28","author":"Hankey","year":"1997","journal-title":"Stroke"},{"key":"R215-4-20210203","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00003246-199505000-00026","article-title":"Validation and comparison of models predicting survival following intracerebral hemorrhage","volume":"23","author":"Tuhrim","year":"1995","journal-title":"Crit Care Med"},{"key":"R216-4-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01428504","article-title":"Urokinase infusion for severe intraventricular haemorrhage","volume":"134","author":"Rainov","year":"1995","journal-title":"Acta Neurochir Wien"},{"key":"R217-4-20210203","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00006123-199803000-00042","article-title":"Secondary hemorrhage after intraventricular fibrinolysis: a cautionary note: a report of two cases","volume":"42","author":"Schwarz","year":"1998","journal-title":"Neurosurgery"},{"key":"R218-4-20210203","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/archneur.57.12.1710","article-title":"Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk","volume":"57","author":"Phan","year":"2000","journal-title":"Arch Neurol"},{"key":"R219-4-20210203","first-page":"IV123","article-title":"Efficacy of nimodipine in cerebral ischemia or hemorrhage","volume":"21","author":"Teasdale","year":"1990","journal-title":"Stroke"},{"key":"R220-4-20210203","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen","year":"1983","journal-title":"N Engl J Med"},{"key":"R221-4-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1227\/00006123-198209000-00001","article-title":"Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension","volume":"11","author":"Kassell","year":"1982","journal-title":"Neurosurgery"},{"key":"R222-4-20210203","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/01.STR.31.2.383","article-title":"Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial","volume":"31","author":"Lennihan","year":"2000","journal-title":"Stroke"},{"key":"R223-4-20210203","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3171\/jns.1995.82.5.0786","article-title":"Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage: a report of the Cooperative Aneurysm Study","volume":"82","author":"Haley","year":"1995","journal-title":"J Neurosurg"},{"key":"R225-4-20210203","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.54.1.77","article-title":"Antifibrino-lytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial","volume":"54","author":"Roos","year":"2000","journal-title":"Neurology"},{"key":"R226-4-20210203","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1161\/01.STR.31.6.1256","article-title":"Urokinase cisternal irrigation therapy for prevention of symp-tomatic vasospasm after aneurysmal subarach-noid hemorrhage: a study of urokinase concentra-tion and the fibrinolytic system","volume":"31","author":"Tatsuya","year":"2000","journal-title":"Stroke"},{"key":"R227-4-20210203","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003086-200306000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:46:04Z","timestamp":1734169564000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-200305000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":225,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003]]}},"URL":"https:\/\/doi.org\/10.1097\/01.crd.0000053459.09918.92","relation":{},"ISSN":["1061-5377"],"issn-type":[{"type":"print","value":"1061-5377"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}